The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darwiche, R.
Right arrow Articles by Kay, T. W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darwiche, R.
Right arrow Articles by Kay, T. W. H.
The Journal of Immunology, 2003, 170: 6292-6297.
Copyright © 2003 by The American Association of Immunologists

Fas Is Detectable on {beta} Cells in Accelerated, But Not Spontaneous, Diabetes in Nonobese Diabetic Mice1

Rima Darwiche*, Mark M. W. Chong{dagger}, Pere Santamaria{ddagger}, Helen E. Thomas* and Thomas W. H. Kay2,*

* St. Vincent’s Institute of Medical Research, Fitzroy, Australia, {dagger} Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; and {ddagger} Department of Microbiology and Infectious Diseases and Julia McFarlane Diabetes Research Center, Faculty of Medicine, University of Calgary, Alberta, Canada

Fas (CD95) is a potential mechanism of pancreatic {beta} cell death in type 1 diabetes. {beta} cells do not constitutively express Fas but it is induced by cytokines. The hypothesis of this study is that Fas expression should be measurable on {beta} cells for them to be killed by this mechanism. We have previously reported that up to 5% of {beta} cells isolated from nonobese diabetic (NOD) mice are positive for Fas expression by flow cytometry using autofluorescence to identify {beta} cells. We have now found that these are not {beta} cells but contaminating dendritic cells, macrophages, and B lymphocytes. In contrast {beta} cells isolated from NODscid mice that are recipients of T lymphocytes from diabetic NOD mice express Fas 18–25 days after adoptive transfer but before development of diabetes. Fas expression on {beta} cells was also observed in BDC2.5, 8.3, and 4.1 TCR-transgenic models of diabetes in which diabetes occurs more rapidly than in unmodified NOD mice. In conclusion, Fas is observed on {beta} cells in models of diabetes in which rapid {beta} cell destruction occurs. Its expression is likely to reflect differences in the intraislet cytokine environment compared with the spontaneous model and may indicate a role for this pathway in {beta} cell destruction in rapidly progressive models.




This article has been cited by other articles:


Home page
DiabetesHome page
K. Pechhold, X. Zhu, V. S. Harrison, J. Lee, S. Chakrabarty, K. Koczwara, O. Gavrilova, and D. M. Harlan
Dynamic Changes in Pancreatic Endocrine Cell Abundance, Distribution, and Function in Antigen-Induced and Spontaneous Autoimmune Diabetes
Diabetes, May 1, 2009; 58(5): 1175 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. L. Graham, N. Sanders, Y. Tan, J. Allison, T. W. H. Kay, and B. S. Coulson
Rotavirus Infection Accelerates Type 1 Diabetes in Mice with Established Insulitis
J. Virol., July 1, 2008; 82(13): 6139 - 6149.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Krishnamurthy, L. Mariana, S. A. Gellert, P. G. Colman, L. C. Harrison, A. M. Lew, P. Santamaria, H. E. Thomas, and T. W. H. Kay
Autoimmunity to Both Proinsulin and IGRP Is Required for Diabetes in Nonobese Diabetic 8.3 TCR Transgenic Mice
J. Immunol., April 1, 2008; 180(7): 4458 - 4464.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. L. Dudek, H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew, et al.
Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways
Diabetes, September 1, 2006; 55(9): 2412 - 2418.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Estella, M. D. McKenzie, T. Catterall, V. R. Sutton, P. I. Bird, J. A. Trapani, T. W. Kay, and H. E. Thomas
Granzyme B-Mediated Death of Pancreatic {beta}-Cells Requires the Proapoptotic BH3-Only Molecule Bid.
Diabetes, August 1, 2006; 55(8): 2212 - 2219.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K.-T. T. Nguyen, P. Tajmir, C. H. Lin, N. Liadis, X.-D. Zhu, M. Eweida, G. Tolasa-Karaman, F. Cai, R. Wang, T. Kitamura, et al.
Essential Role of Pten in Body Size Determination and Pancreatic {beta}-Cell Homeostasis In Vivo
Mol. Cell. Biol., June 15, 2006; 26(12): 4511 - 4518.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. D McKenzie, N. L Dudek, L. Mariana, M. M. Chong, J. A Trapani, T. W. Kay, and H. E Thomas
Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL
Int. Immunol., June 1, 2006; 18(6): 837 - 846.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Lu, T. Ventura-Holman, J. Li, R. W. McMurray, J. S. Subauste, and J. F. Maher
Abnormal Glucose Homeostasis and Pancreatic Islet Function in Mice with Inactivation of the Fem1b Gene
Mol. Cell. Biol., August 1, 2005; 25(15): 6570 - 6577.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Allison, H. E. Thomas, T. Catterall, T. W. H. Kay, and A. Strasser
Transgenic Expression of Dominant-Negative Fas-Associated Death Domain Protein in {beta} Cells Protects against Fas Ligand-Induced Apoptosis and Reduces Spontaneous Diabetes in Nonobese Diabetic Mice
J. Immunol., July 1, 2005; 175(1): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath
Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics
J. Immunol., March 1, 2005; 174(5): 2746 - 2755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. W. Chong, Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. H. Kay, and H. E. Thomas
Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction
J. Immunol., May 1, 2004; 172(9): 5714 - 5721.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
U. Christen, R. Darwiche, H. E. Thomas, T. Wolfe, E. Rodrigo, A. Chervonsky, R. A. Flavell, and M. G. von Herrath
Virally Induced Inflammation Triggers Fratricide of Fas-Ligand-Expressing {beta}-Cells
Diabetes, March 1, 2004; 53(3): 591 - 596.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. E. Thomas, W. Irawaty, R. Darwiche, T. C. Brodnicki, P. Santamaria, J. Allison, and T. W.H. Kay
IL-1 Receptor Deficiency Slows Progression to Diabetes in the NOD Mouse
Diabetes, January 1, 2004; 53(1): 113 - 121.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.